MAP2K5 and cancer: Of particular interest amongst the putative hits identified within this screen was ERK5 (also known as MAPK7 and MEK5), as it has recently been identified as a potential oncogenic factor in several other cancers [6,7,8,9,10,11,18,19,20], and several potential therapeutic small molecule inhibitors have recently been developed [12,13,14,15,21].